teaser
A major drug maker has warned about a shortage of its hypertension drug due to manufacturing problems.
Pfizer said there will be a reduced supply of Cardura XL (doxasozin mesilate) 8mg until October.
A spokeswoman for the drug manufacturer said: “We make every effort to ensure that our products are in stock at all times but have been experiencing delays due to manufacturing issues.
↓Article continues below this sponsored advert↓
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
↑Advertisement↑
“We regret any inconvenience caused by this and advise patients or carers concerned by this or any aspect of their medication to contact their clinicians for further advice.”
Copyright Press Association 2010
